Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma

BACKGROUND: Prognostic factors for stage IIIA lung adenocarcinoma (LUAD) are unclear. The current main treatment for stage IIIA LUAD is still controversial. Some Clinicians advocate synchronous chemoradiotherapy as the main treatment for stage IIIA LUAD. In contrast, some clinicians argue that there...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiuzhen, Lin, Xuefeng, Li, Xin, Zhang, Weiran, Sun, Daqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908182/
https://www.ncbi.nlm.nih.gov/pubmed/35280419
http://dx.doi.org/10.21037/atm-22-130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908182/
https://www.ncbi.nlm.nih.gov/pubmed/35280419
http://dx.doi.org/10.21037/atm-22-130

Ejemplares similares